Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease

Virology

Volumn 363, Issue 1, 2007, Pages 156-165

  Sponseller, Brett A ^a   Sparks, Wendy O ^a   Wannemuehler, Yvonne ^a   Li, Yuxing ^a   Antons, Amanda K ^a   Oaks, J Lindsay ^b   Carpenter, Susan ^a,b  

^a IOWA STATE UNIVERSITY   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Antigenic variation; Broadly neutralizing antibody; Equine infections anemia virus; Lentivirus persistence

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENVELOPE GENE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HORSE DISEASE; IMMUNE RESPONSE; INOCULATION; LONGITUDINAL STUDY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS NEUTRALIZATION; VIRUS VIRULENCE;

ACUTE DISEASE; AMINO ACID SEQUENCE; ANIMALS; CARRIER STATE; CELL LINE; CHRONIC DISEASE; DISEASE PROGRESSION; DOGS; EQUINE INFECTIOUS ANEMIA; EVOLUTION, MOLECULAR; GENE PRODUCTS, ENV; GENOTYPE; HORSES; INFECTIOUS ANEMIA VIRUS, EQUINE; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; SELECTION (GENETICS); TIME FACTORS; VARIATION (GENETICS);

EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; LENTIVIRUS;

EID: 34247608684     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.01.037     Document Type: Article

References (38)

1. Ball J.M., Rushlow K.E., Issel C.J., and Montelaro R.C. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies. J. Virol. 66 (1992) 732-742
2. Belshan M., Baccam P., Oaks J.L., Sponseller B.A., Murphy S.C., Cornette J., and Carpenter S. Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony. Virology 279 (2001) 185-200
3. Carpenter S., and Chesebro B. Change in host cell tropism associated with in vitro replication of equine infectious anemia virus. J. Virol. 63 (1989) 2492-2496
4. Carpenter S., Evans L.H., Sevoian M., and Chesebro B. Role of the host immune response in selection of equine infectious anemia virus variants. J. Virol. 61 (1987) 3783-3789
5. Carpenter S., Evans L.H., Sevoian M., and Chesebro B. In vivo and in vitro selection of equine infectious anemia virus variants. In: Kurstak E., Marusyk R.G., Murphy F.A., and Van Regenmortel M.H.V. (Eds). Applied Virology Research II: Virus Variation, Epidemiology, and Control (1990), Plenum Publishing, New York 99-115
6. Dacheux L., Moreau A., Ataman-Onal Y., Biron F., Verrier B., and Barin F. Evolutionary dynamics of the glycan shield of the human immunodeficiency virus envelope during natural infection and implications for exposure of the 2G12 epitope. J. Virol. 78 (2004) 12625-12637
7. Gray T.A., Hernandez L., Carey A.H., Schaldach M.A., Smithwick M.J., Rus K., Graves J.A.M., Stewart C.L., and Nicholls R.D. The ancient source of a distinct gene family encoding proteins featuring RING and C3H Zinc-Finger motifs with abundant expression in developing brain and nervous system. Genomics 66 (2000) 76-86
8. Gray T.A., Azama K., Whitmore K., Min A., Abe S., and Nicholls R.D. Phylogenetic conservation of the Makorin-2 gene, encoding a multiple zinc-finger protein, antisense to the RAF1 proto-oncogene. Genomics 77 (2001) 119-126
9. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 45 (1999) 95-98
10. Hammond S.A., Cook S.J., Lichtenstein D.L., Issel C.J., and Montelaro R.C. Maturation of the cellular and humoral immune responses to persistant infection in horses by equine infectious anemia virus is a complex and lengthy process. J. Virol. 71 (1997) 3840-3852
11. Hammond S.A., Li F., McKeon B.M., Cook S.J., Issel C.J., and Montelaro R.C. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus. J. Virol. 74 (2000) 5968-5981
12. Howe L., Leroux C., Issel C.J., and Montelaro R.C. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype. J. Virol. 76 (2002) 10588-10597
13. Hussain K.A., Issel C.J., Schnorr K.L., Rwambo P.M., and Montelaro R.C. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies. J. Virol. 61 (1987) 2956-2961
14. Joos B., Trkola A., Fischer M., Kuster H., Rusert P., Leemann C., Boni J., Oxenius A., Price D.A., Phillips R.E., Wong J.K., Hirschel B., Weber R., and Gunthard H.F. Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions. J. Virol. 79 14 (2005) 9026-9037
15. Kono Y. Antigenic variation of equine infectious anemia virus as detected by virus neutralization. Arch. Virol. 98 (1988) 91-97
16. Kono Y., Kobayashi K., and Fukunaga Y. Antigenic drift of equine infectious anemia virus in chronically infected horses. Arch. Ges. Virus. Forsch. 41 (1973) 1-10
17. Leroux C., Issel C.J., and Montelaro R.C. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. J. Virol. 71 (1997) 9627-9639
18. Leroux C., Craigo J.K., Issel C.J., and Montelaro R.C. Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies. J. Virol. 75 (2001) 4570-4583
19. Malmquist W.A., Burnett D., and Becvar C.S. Production of equine infectious anemia antigen in a persistently infected cell line. Arch. Gesamte Virusforsch. 42 (1973) 361-370
20. McGuire T.C., Fraser D.G., and Mealey R.H. Cytotoxic T lymphocytes and neutralizing antibody in the control of equine infectious anemia virus. Viral Immunol. 15 (2002) 521-531
21. Nakowitsch S., Quendler H., Fekete H., Kunert R., Katinger H., and Stiegler G. HIV-1 mutants escaping neutralization by the human antibodies 2F5, 2G12, and 4E10: in vitro experiments versus clinical studies. AIDS 19 17 (2005) 1957-1966
22. Oaks J.L., McGuire T.C., Ulibarri C., and Crawford T.B. Equine infectious anemia virus is found in tissue macrophages during subclinical infection. J. Virol. 72 (1998) 7263-7269
23. O'Rourke K., Perryman L.E., and McGuire T.C. Antiviral, anti-glycoprotein and neutralizing antibodies in foals with equine infectious anaemia virus. J. Gen. Virol. 69 Pt. 3 (1988) 667-674
24. O'Rourke K.I., Perryman L.E., and McGuire T.C. Cross-neutralizing and subclass characteristics of antibody from horses with equine infectious anemia virus. Vet. Immunol. Immunopathol. 23 (1989) 41-49
25. Pang H., Kong X.-G., Sentsui H., Kono Y., Sugiura T., Hasegawa A., and Akaski H. Genetic variation of envelope gp90 gene of equine infectious anemia virus isolated from an experimentally infected horse. J. Vet. Med. Sci. 59 (1997) 1089-1095
26. Payne S., Parekh B., Montelaro R.C., and Issel C.J. Genomic alterations associated with persistent infections by equine infectious anemia virus, a retrovirus. J. Gen. Virol. 65 (1984) 1395-1399
27. Payne S.L., Rausch J., Rushlow K., Montelaro R.C., Issel C., Flaherty M., Perry S., Sellon D., and Fuller F. Characterization of infectious molecular clones of equine infectious anaemia virus. J. Gen. Virol. 75 (1994) 425-429
28. Raabe M.R., Issel C.J., and Montelaro R.C. Equine monocyte-derived macrophage cultures and their applications for infectivity and neutralization studies of equine infectious anemia virus. J. Virol. Methods 71 (1998) 87-104
29. Rwambo P.M., Issel C.J., Adams Jr. W.V., Hussain K.A., Miller M., and Montelaro R.C. Equine infectious anemia virus (EIAV). Humoral responses of recipient ponies and antigenic variation during persistent infection. Arch. Virol. 111 (1990) 199-212
30. Salinovich O., Payne S.L., Montelaro R.C., Hussain K.A., Issel C.J., and Schnorr K.L. Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection. J. Virol. 57 (1986) 71-80
31. Sellon D.C., Perry S.T., Coggins L., and Fuller F.J. Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes. J. Virol. 66 (1992) 5906-5913
32. Sellon D.C., Fuller F.J., and McGuire T.C. The immunopathogenesis of equine infectious anemia virus. Virus Res. 32 (1994) 111-138
33. Smith T.A., Davis E., and Carpenter S. Endotoxin treatment of EIAV-infected horse macrophage cultures decreases production of infectious virus. J. Gen. Virol. 79 (1998) 747-755
34. Spyrou V., Papanastassopoulou M., Koumbati M., Nikolakaki S.V., and Koptopoulos G. Molecular analysis of the proviral DNA of equine infectious anemia virus in mules in Greece. Virus Res. 107 1 (2005) 63-72
35. Wei X., Decker J., Wang S., Hui H., Kappes J., Wu X., Salazar-Gonzalz J., Salazar M., Kilby J.M., Saag M., Komarova N., Nowak M., Hahn B., Kwong P., and Shaw G. Antibody neutralization and escape by HIV-1. Nature 422 (2003) 307-312
36. Zheng Y.H., Nakaya T., Sentsui H., Kameoka M., Kishi M., Hagiwara K., Takahashi H., Kono Y., and Ikuta K. Insertions, duplications and substitutions in restricted gp90 regions of equine infectious anaemia virus during febrile episodes in an experimentally infected horse. J. Gen. Virol. 78 (1997) 807-820
37. Zheng Y., Sentsui H., Nakaya T., Kono Y., and Ikuta K. In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: insertions/duplications at the principal neutralizing domain. J. Virol. 7 (1997) 5031-5039
38. Zheng Y., Sentsui H., Sugita M., Nakaya T., Kishi M., Hagiwara K., Inoshima Y., Ishihara C., Kono Y., Lu J., and Ikuta K. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain. Virology 266 (2000) 129-139